Health Canada has approved the first drug designed to treat postpartum depression. The regulator says zuranolone, a pill sold ...

A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for ...

NEW YORK (WABC) -- The Food and Drug Administration is reviewing the application for a new medication, which, if approved, would become the first drug specifically indicated for postpartum depression.

Zuranolone is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days ...

Miriam McDonald, who developed severe postpartum depression and suicidal ideation after giving birth in late 2019, battled Kaiser Permanente for more than a year to find effective treatment. Her ...